About the Authors
- Laura Musazzi
-
Contributed equally to this work with: Laura Musazzi, Marco Milanese
Affiliation Department of Pharmacological Sciences, Center of Neuropharmacology and Center of Excellence on Neurodegenerative Diseases, University of Milano, Milano, Italy
- Marco Milanese
-
Contributed equally to this work with: Laura Musazzi, Marco Milanese
Affiliations Department of Experimental Medicine, Section of Pharmacology and Toxicology, University of Genova, Genova, Italy, Center of Excellence for Biomedical Research and National Institute of Neuroscience, Genova, Italy
- Pasqualina Farisello
-
Affiliations Department of Neuroscience and Brain Technologies, The Italian Institute of Technology, Genova, Italy, Department of Experimental Medicine, Section of Physiology, University of Genova and National Institute of Neuroscience, Genova, Italy
- Simona Zappettini
-
Affiliations Department of Experimental Medicine, Section of Pharmacology and Toxicology, University of Genova, Genova, Italy, Center of Excellence for Biomedical Research and National Institute of Neuroscience, Genova, Italy
- Daniela Tardito
-
Affiliation Department of Pharmacological Sciences, Center of Neuropharmacology and Center of Excellence on Neurodegenerative Diseases, University of Milano, Milano, Italy
- Valentina S. Barbiero
-
Affiliation Department of Pharmacological Sciences, Center of Neuropharmacology and Center of Excellence on Neurodegenerative Diseases, University of Milano, Milano, Italy
- Tiziana Bonifacino
-
Affiliations Department of Experimental Medicine, Section of Pharmacology and Toxicology, University of Genova, Genova, Italy, Center of Excellence for Biomedical Research and National Institute of Neuroscience, Genova, Italy
- Alessandra Mallei
-
Affiliation Department of Pharmacological Sciences, Center of Neuropharmacology and Center of Excellence on Neurodegenerative Diseases, University of Milano, Milano, Italy
- Pietro Baldelli
-
Affiliations Department of Neuroscience and Brain Technologies, The Italian Institute of Technology, Genova, Italy, Department of Experimental Medicine, Section of Physiology, University of Genova and National Institute of Neuroscience, Genova, Italy
- Giorgio Racagni
-
Affiliations Department of Pharmacological Sciences, Center of Neuropharmacology and Center of Excellence on Neurodegenerative Diseases, University of Milano, Milano, Italy, Department of Experimental Medicine, Section of Pharmacology and Toxicology, University of Genova, Genova, Italy, Department of Neuroscience and Brain Technologies, The Italian Institute of Technology, Genova, Italy, Istituto di Ricovero e Cura a Carattere Scientifico San Giovanni di Dio - Fatebenefratelli, Brescia, Italy, Center of Excellence for Biomedical Research and National Institute of Neuroscience, Genova, Italy, Department of Experimental Medicine, Section of Physiology, University of Genova and National Institute of Neuroscience, Genova, Italy
- Maurizio Raiteri
-
Affiliations Department of Experimental Medicine, Section of Pharmacology and Toxicology, University of Genova, Genova, Italy, Center of Excellence for Biomedical Research and National Institute of Neuroscience, Genova, Italy
- Fabio Benfenati
-
Affiliations Department of Neuroscience and Brain Technologies, The Italian Institute of Technology, Genova, Italy, Department of Experimental Medicine, Section of Physiology, University of Genova and National Institute of Neuroscience, Genova, Italy
- Giambattista Bonanno
-
¶These authors also contributed equally to this work.
Affiliations Department of Experimental Medicine, Section of Pharmacology and Toxicology, University of Genova, Genova, Italy, Center of Excellence for Biomedical Research and National Institute of Neuroscience, Genova, Italy
- Maurizio Popoli
-
* E-mail: maurizio.popoli@unimi.it
¶These authors also contributed equally to this work.
Affiliation Department of Pharmacological Sciences, Center of Neuropharmacology and Center of Excellence on Neurodegenerative Diseases, University of Milano, Milano, Italy
Competing Interests
MP and GR declare they are acting as consultants for Servier Pharmaceuticals (France). All other authors declare no conflict of interest. This does not alter our adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.
Author Contributions
Conceived and designed the experiments: PB GR MR FB GB MP. Performed the experiments: LM MM PF SZ VSB TB AM. Analyzed the data: LM MM PF SZ DT AM PB GB. Wrote the paper: LM FB GB MP.